No connection

Search Results

EHC vs TEM

EHC
Encompass Health Corporation
BULLISH
Price
$101.98
Market Cap
$10.14B
Sector
Healthcare
AI Confidence
85%
TEM
Tempus AI, Inc.
BEARISH
Price
$56.78
Market Cap
$10.19B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
EHC
18.37
TEM
--
Forward P/E
EHC
15.74
TEM
-628.03
P/B Ratio
EHC
4.18
TEM
20.58
P/S Ratio
EHC
1.71
TEM
8.01
EV/EBITDA
EHC
9.86
TEM
-62.52

Profitability

Gross Margin
EHC
43.21%
TEM
62.74%
Operating Margin
EHC
18.35%
TEM
-16.7%
Profit Margin
EHC
9.54%
TEM
-19.27%
ROE
EHC
24.82%
TEM
-89.48%
ROA
EHC
9.66%
TEM
-9.66%

Growth

Revenue Growth
EHC
9.9%
TEM
83.0%
Earnings Growth
EHC
21.2%
TEM
--

Financial Health

Debt/Equity
EHC
0.83
TEM
2.7
Current Ratio
EHC
1.08
TEM
3.13
Quick Ratio
EHC
0.83
TEM
2.88

Dividends

Dividend Yield
EHC
0.75%
TEM
--
Payout Ratio
EHC
12.97%
TEM
0.0%

AI Verdict

EHC BULLISH

EHC presents a stable financial profile with a Piotroski F-Score of 4/9 and a significant valuation gap between its defensive Graham Number ($55.18) and growth-based Intrinsic Value ($163.72). The company exhibits exceptional operational efficiency with an ROE of 24.82% and a highly attractive PEG ratio of 0.41, suggesting the stock is undervalued relative to its earnings growth. While insider sentiment is bearish and technical trends are currently weak, the long-term fundamental trajectory is supported by a 25-quarter track record of consistent earnings beats. The current price of $101.98 represents a reasonable entry point given the analyst target of $142.73.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Very low PEG ratio (0.41) indicating strong growth at a reasonable price
High Return on Equity (24.82%) demonstrating efficient capital use
Risks
Bearish insider activity with significant selling by the CEO and other officers
Weak technical trend (0/100) indicating short-term price momentum is negative
Tight liquidity with a current ratio of 1.08
TEM BEARISH

Tempus AI exhibits critical financial fragility, highlighted by a Piotroski F-Score of 1/9, indicating severe weakness across profitability and operational efficiency. While the company demonstrates explosive revenue growth of 83% YoY, this is offset by deep negative margins and a high Debt/Equity ratio of 2.70. The bearish outlook is further reinforced by aggressive insider selling, including significant divestments by the CEO and CFO, and a technical trend score of 0/100. Despite analyst optimism, the fundamental health metrics suggest a high-risk profile.

Strengths
Exceptional YoY revenue growth of 83.00%
Strong Q/Q revenue growth of 82.98%
Healthy liquidity with a Current Ratio of 3.13
Risks
Critical financial health (Piotroski F-Score 1/9)
Heavy insider selling totaling $43.97M with zero insider buys
High leverage with a Debt/Equity ratio of 2.70

Compare Another Pair

EHC vs TEM: Head-to-Head Comparison

This page compares Encompass Health Corporation (EHC) and Tempus AI, Inc. (TEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile